Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer-Reference-Cited by-同舟云学术

Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer

Published:2010-05-14 Issue:5 Volume:5 Page:e10630
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Hwang Jin-Hyeok,Voortman Johannes,Giovannetti Elisa,Steinberg Seth M.,Leon Leticia G.,Kim Yong-Tae,Funel Niccola,Park Joo Kyung,Kim Min A.,Kang Gyeong Hoon,Kim Sun-Whe,Chiaro Marco Del,Peters Godefridus J.,Giaccone Giuseppe

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference66 articles.

1. Cancer statistics, 2009.;A Jemal;CA Cancer J Clin,2009

2. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database.;SF Sener;J Am Coll Surg,1999

3. Adjuvant therapy for pancreatic cancer: a review.;DS Zuckerman;Cancer,2008

4. The role of adjuvant chemotherapy for patients with resected pancreatic cancer: systematic review of randomized controlled trials and meta-analysis.;S Boeck;Oncology,2007

5. Adjuvant therapy for surgically resected pancreatic adenocarcinoma.;JL Abbruzzese;Jama,2008

Cited by 263 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Personalized treatment using predictive biomarkers in solid organ malignancies: A review;Tumori Journal;2024-08-02

2. The Multifaceted Role of miR-21 in Pancreatic Cancers;Cells;2024-05-30

3. miRNAs in pancreatic cancer progression and metastasis;Clinical & Experimental Metastasis;2024-01-19

4. The application of RNA sequencing in precision cancer medicine;Comprehensive Precision Medicine;2024

5. Functional and Potential Therapeutic Implication of MicroRNAs in Pancreatic Cancer;International Journal of Molecular Sciences;2023-12-15